mounjaro vs zepbound access is a mess
Company: Eli Lilly
Tags: field, quota, strategy
same mechanism. different prior auth. different formulary tier. different payer criteria. same patient population. home office calls it a messaging problem. its a structural access problem. losing real scripts over it
11 upvotes · 5 comments